Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 0 | 0 | 0 | 46,861 | 3,888 |
| Gross Profit | N/A | N/A | N/A | 46,861 | 3,888 |
| Operating Expenses | 9,175 | 36,733 | 19,493 | 65,752 | 144,462 |
| Operating Income | -9,175 | -36,733 | -19,493 | -18,891 | -140,574 |
| Interest Expense | 8 | 185 | 178 | 0 | 588 |
| Other Income | 763 | 25,499 | 240 | 6,590 | 8,385 |
| Pre-tax Income | -8,420 | -11,419 | -19,431 | -12,301 | -132,777 |
| Income Tax | N/A | -2,281 | N/A | N/A | N/A |
| Net Income Continuous | -8,420 | -9,138 | -19,431 | -12,301 | -132,777 |
| Net Income | $-8,420 | $-9,138 | $-19,431 | $-12,301 | $-130,553 |
| EPS Basic Total Ops | -8,973.20 | -12,870.65 | -233,122.00 | -41,784.31 | -2.54 |
| EPS Basic Continuous Ops | -8,972.20 | -11,678.71 | -232,347.60 | -41,805.14 | -2.58 |
| EPS Diluted Total Ops | -8,973.20 | -12,870.65 | -233,122.00 | -41,784.31 | -2.54 |
| EPS Diluted Continuous Ops | -8,972.20 | -11,678.71 | -232,347.60 | -41,805.14 | -2.58 |
| EBITDA(a) | $-8,837 | $-36,276 | $-19,273 | $-16,548 | $-137,392 |